Key Insights

Highlights

Treatment Research

6 treatments under study, led by Doxycycline

Research Leaders

8 sponsors active, led by National Institute Of Allergy And Infectious Diseases Niaid

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 80/100

Termination Rate

33.3%

1 terminated out of 3 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

1 of 0 completed with results

Key Signals

1 with results0

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 4 (1)

Trial Status

Terminated1
Not Yet Recruiting1
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT06743204Not ApplicableRecruiting

The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study

NCT07704957Phase 4Not Yet RecruitingPrimary

A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States

NCT03098394Not ApplicableTerminated

Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections

Showing all 3 trials

Research Network

Common Treatments

  • Doxycycline1
  • Polymerase Chain Reaction Pcr1
  • Cepheid Xpert Ctng Rapid Turnaround Test1
  • Selfreported Risk Screening For Prep And Diagnostic Sti Testing1
  • Selfreported Risk Screening For Prep And Syndromic Management For Stis1

Active Sponsors

  • National Institute Of Allergy And Infectious Diseases Niaid2
  • Bill And Melinda Gates Foundation1
  • Tulane University1
  • Abbott1
  • Louisiana State University Health Sciences Center In New Orleans1

Related Conditions

  • Gonorrhea Female3
  • Syphilis Female2
  • Prophylaxis1
  • Sexually Transmitted Infection1
  • Hiv1

Activity Timeline